Add Yahoo as a preferred source to see more of our stories on Google. BrainIAC, a new AI model, analyzes brain MRIs to predict dementia risk, tumor mutations, and brain cancer survival. (CREDIT: ...

Panelists discuss how the 5-year CROWN trial data for lorlatinib have shaped the treatment paradigm for ALK+ metastatic non-small cell lung cancer (NSCLC), particularly regarding long-term survival, ...

Brain radiotherapy combined with ICIs improved overall survival and intracranial local control in SCLC patients with brain metastases. WBRT with simultaneous integrated boost (SIB) showed better ...

Patients who received a focused ultrasound treatment to aid drug delivery increased their odds of surviving the deadliest form of brain cancer by nearly 40%, according to a study led by University of ...

Patritumab deruxtecan showed no overall survival benefit over chemotherapy in EGFR mutation-positive NSCLC patients. The drug demonstrated a slight progression-free survival advantage and higher ...

Add Yahoo as a preferred source to see more of our stories on Google. Cancer Cell Spread and oncology or Malignant Cancerous Growth and Metastasis anatomy concept as growing tumor cells and Malignancy ...

ATLANTA — Stereotactic radiosurgery (SRS) alone should be the favored first-line radiation therapy option for cancer patients younger than 50 years of age who have a minimal number of brain metastases ...

Mass General Brigham researchers are betting that the next big leap in brain medicine will come from teaching artificial intelligence to “read” MRI scans in a more flexible way. The team, led by ...